Bill Frist, M.D. sits down (virtually) with renowned immunologist Dr. James Hildreth, CEO of Meharry Medical College. Such a rich conversation on science, equity and innovation you don’t want to miss: https://lnkd.in/gHWzXrJ
The current trial process is time consuming and costly. It costs, on average, $2.6 billion to bring a new treatment to patients including each approved drug must cover its own costs as well as the cos
For years, technology and software companies, as well as CROs, have been pitching the benefits of patient-centric technologies to sponsor companies. FDA guidance on protecting the safety of patients s
